Who is sponsoring NCT01801774?

NCT01801774 is sponsored by Mahidol University.

What condition does NCT01801774 study?

NCT01801774 studies Inflammation, Intraocular Pressure.

What drugs are being tested in NCT01801774?

Interventions: Subtenon 20-mg triamcinolone injection, Placebo.

What is the status of NCT01801774?

NCT01801774 is currently UNKNOWN.

Last reviewed 2015-03-31 · How we verify

Quantitative Comparison of the Efficacy of Subtenon 20-mg Triamcinolone Injection With 0.1% Dexamethasone Eye Drop in Controlling Intraocular Inflammation After Phacoemulsification

NCT01801774 Phase 4 UNKNOWN

Phacoemulsification is a quick method with less complication for cataract surgery. Due to the use of ultrasonic energy, it produced more post-operative inflammation than other methods. Many routes of steroid had been used to control post-operative inflammation. The investigators here compare the efficacy of single depot steroid subtenon injection (20-mg triamcinolone) with four-time-a-day steroid eye drop (0.1% dexamethasone) in controlling inflammation after uneventful phacoemulsification.

Details

Lead sponsor	Mahidol University
Phase	Phase 4
Status	UNKNOWN
Enrolment	140
Start date	2012-05
Completion	2015-07

Conditions

Inflammation
Intraocular Pressure

Interventions

Subtenon 20-mg triamcinolone injection
Placebo

Primary outcomes

Anterior chamber reaction — postoperative day 28
proportion of anterior chamber reaction grade 0 measured by anterior chamber inflammation score at postoperative day 28+/-5

Countries

Thailand